Around 5% of US Population Diagnosed With Autoimmune DiseaseJanuary 14, 2025Rare DiseasesEndocrinologyDermatologyGastroenterologyImmunologyNeurologyRheumatology
Most Kids With COVID-Linked MIS-C Recover by 6 MonthsJanuary 14, 2025COVID-19 UpdatesInfectious DiseasesCardiologyRare DiseasesPediatricsRheumatology
Alpha-Gal Syndrome: 5 Things to KnowDecember 19, 2024ImmunologyDermatologyGastroenterologyPreventive CareRare Diseases
Health Impacts of Micro- and NanoplasticsDecember 17, 2024EndocrinologyPulmonologyWomen's HealthNeurologyDigestive HealthHepatologyRare Diseases
First Phase 3 Drug Trial in IgG4-Related Disease Has SuccessNovember 18, 2024NephrologyGastroenterologyNeurologyRheumatologyRare DiseasesPulmonology
Scurvy: A Diagnosis Still Relevant TodayNovember 8, 2024GastroenterologyRare DiseasesDermatologyHematologyRheumatologyNeurology
Pediatric Myasthenia Gravis: Don’t Treat Children Like AdultsOctober 22, 2024PediatricsRare DiseasesNeurology
Benralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Rare DiseasesRheumatologyNephrologyPulmonologyAsthma
Neurofibromatosis: What Affects Quality of Life Most?September 4, 2024Rare DiseasesDermatologyMental HealthMixed Topics
Dermatofibrosarcoma Protuberans More Common In Black Patients, Analysis FindsJuly 2, 2024Rare DiseasesDiversity in MedicineDermatologyOncology
Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024PediatricsRare DiseasesMusculoskeletal DisordersDermatologyRheumatologyGastroenterology
First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic ArthritisJune 26, 2024PediatricsRare DiseasesMusculoskeletal Disorders
VEXAS Syndrome: Study Highlights Cutaneous SymptomsJune 20, 2024Rare DiseasesDermatologyRheumatologyMixed Topics
